Saxenda is a synthetic weight loss drug, which can cause a few types of side effects including gastrointestinal, cardiometabolic and psychiatric ones.
About 10% of patients involved in clinical trials were forced to stop using Saxenda because of pronounced side effects. The most common reasons for Saxenda cancellation because of side effects were severe nausea, vomiting and diarrhea.
These side effects are mild or do not arise at all in the vast majority of people. Thus, the risk of side effects does not exceed the potential benefits of Saxenda to the health of obese patients.
Besides the listed gastrointestinal side effects, Saxenda can cause heartburn, constipation, abdominal pain, dry mouth, indigestion, belching, excessive accumulation of gas in the intestines, bloating, headache, dizziness, anxiety and insomnia.
Because of Saxenda ability to cause a large number of gastrointestinal side effects, patients with gastrointestinal diseases should use it with caution.
Not all Saxenda side effects are listed in this review. A full list of Saxenda side effects can be found in:
• Product Monograph for Saxenda – approved by Health Canada.
• Summary of Product Characteristics for Saxenda – approved by EMA.
• Highlights of Prescribing Information for Saxenda – approved by FDA.
It should be noted that obese people with low income and without insurance are not able to buy Saxenda. The cost of the obesity treatment for a month by means of Saxenda exceeds $1.000. Therefore, tens of millions of uninsured obese Americans do not have the possibility to use this drug for weight loss.
Price of Saxenda will decrease only when the first Saxenda generic drugs will appear at the international market.
However, given the fact that the first Saxenda generic drugs will appear after more than 10 years in developed countries, only those people who today do not pay enough attention to their body weight and timely do not take steps to prevent obesity and fight excess weight will be able to buy cheap Saxenda.
Because of the high price of Saxenda new drug, the vast majority of obese people will still choose oral therapy of obesity. Herewith, current trends show that more and more number of obese inhabitants of developed countries pay a special attention to safe obesity treatment.
Thus, sales of over-the-counter weight loss products grow as intensively as the sales of powerful prescription anorectics that can cause many potentially dangerous side effects.